Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA approves ViiV Healthcare's Tivicay for treatment of HIV-1

Aug. 14, 2013

FDA approves Alere Determine HIV-1/2 Ag/Ab Combo test

Aug. 12, 2013

PrEP trial to evaluate prevention using antiretroviral drugs in HIV-negative individuals

Aug. 2, 2013

Gilead receives positive opinion from EMA for cobicistat

July 29, 2013

Gilead Sciences presents novel agents for HIV infection

July 24, 2013

MBio Diagnostics receives NIH grant to continue development of POC HIV diagnostic device

July 23, 2013

Janssen and Pepscan patent novel polypeptide HIV fusion inhibitors

July 18, 2013

Boehringer Ingelheim divulges novel reverse transcriptase inhibitors

July 12, 2013

Janssen announces approval of a high-dose HIV therapeutic

July 11, 2013

Calimmune commences phase I/II trial of gene medicine for HIV

July 10, 2013

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...